Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancer-Reference-Cited by-同舟云学术

Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancer

Published:2024-01 Issue: Volume:142 Page:106952
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Wu Yiquan,Wu Mingfei,Zheng Xiaoli,Yu Hengyuan,Mao Xinfei,Jin Yuyuan,Wang Yanhong,Pang Ao,Zhang Jingyu,Zeng Shenxin,Xu Tengfei,Chen Yong,Zhang Bo,Lin Nengming,Dai Haibin,Wang Yuwei,Yao Xiaojun,Dong Xiaowu,Huang Wenhai,Che Jinxin

Funder

Zhejiang Province Natural Science Foundation

Key Research and Development Program of Zhejiang Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference31 articles.

1. PARP inhibition: PARP1 and beyond;Rouleau;Nat. Rev. Cancer.,2010

2. The PARP superfamily;Amé;BioEssays,2004

3. PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification;Langelier;Curr. Opin. Struct. Biol.,2018